Nasal vaccine to treat Alzheimer’s disease to be tested in U.S. clinical trial

nasal vaccine to treat alzheimers disease to be tested in u s clinical trial

Sumary of Nasal vaccine to treat Alzheimer’s disease to be tested in U.S. clinical trial:

  • Protollin has been found to be safe in other vaccines, and Weiner told the Boston Herald that his pre-trial research showed that a nasally administered dose provides the best results, and did not reveal any major side effects.
  • researchers investigates changes to heart valve surgery Weiner told the Herald the vaccine “can help with the disease and even more importantly, it can be given to people who are at risk for the disease or have it and don’t know it.
  • Researchers will also track the effect of the vaccine on participants’ immune response by measuring white blood cell counts.
  • Dr. Howard Weiner calls the development of the trial “remarkable.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close